Becoming a thrombectomy-capable stroke center: Clinical and medico-economical effectiveness at the hospital level.

IF 5.8 3区 医学 Q1 CLINICAL NEUROLOGY European Stroke Journal Pub Date : 2024-12-01 Epub Date: 2024-05-17 DOI:10.1177/23969873241254239
Thomas Checkouri, Denis Sablot, Quentin Varnier, Ivan Fryder, Francois-Louis Collemiche, Benoit Azais, Cyril Dargazanli, Franck Leibinger, Federico Cagnazzo, Mehdi Mahmoudi, Pierre-Henri Lefevre, Laurene Van Damme, Gregory Gascou, Julia Schmidt, Caroline Arquizan, Carole Plantard, Geoffroy Farouil, Vincent Costalat
{"title":"Becoming a thrombectomy-capable stroke center: Clinical and medico-economical effectiveness at the hospital level.","authors":"Thomas Checkouri, Denis Sablot, Quentin Varnier, Ivan Fryder, Francois-Louis Collemiche, Benoit Azais, Cyril Dargazanli, Franck Leibinger, Federico Cagnazzo, Mehdi Mahmoudi, Pierre-Henri Lefevre, Laurene Van Damme, Gregory Gascou, Julia Schmidt, Caroline Arquizan, Carole Plantard, Geoffroy Farouil, Vincent Costalat","doi":"10.1177/23969873241254239","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Too few patients benefit from endovascular therapy (EVT) in large vessel occlusion acute stroke (LVOS), and various acute stroke care paradigms are currently investigated to reduce these inequalities in health access. We aimed to investigate whether newly set-up thrombectomy-capable stroke centers (TSC) offered a safe, effective and cost-effective procedure.</p><p><strong>Patients and methods: </strong>This French retrospective study compared the outcomes of LVOS patients with an indication for EVT and treated at the Perpignan hospital before on-site thrombectomy was available (Primary stroke center), and after formation of local radiology team for neurointervention (TSC). Primary endpoints were 3-months functional outcomes, assessed by the modified Rankin scale. Various safety endpoints for ischemic and hemorragic procedural complications were assessed. We conducted a medico-economic analysis to estimate the cost-benefit of becoming a TSC for the hospital.</p><p><strong>Results: </strong>The differences between 422 patients in the PSC and 266 in the TSC were adjusted by the means of weighted logistic regression. Patients treated in the TSC had higher odds of excellent functional outcome (aOR 1.77 [1.16-2.72], <i>p</i> = 0.008), with no significant differences in the rates of procedural complications. The TSC setting shortened onset-to-reperfusion times by 144 min (95% CI [131-155]; <i>p</i> < 0.0001), and was cost-effective after 21 treated LVOS patients. On-site thrombectomy saves 10.825€ per patient for the hospital.</p><p><strong>Discussion: </strong>Our results demonstrate that the TSC setting improves functional outcomes and reduces intra-hospital costs in LVOS patients. TSCs could play a major public health role in acute stroke care and access to EVT.</p>","PeriodicalId":46821,"journal":{"name":"European Stroke Journal","volume":" ","pages":"936-942"},"PeriodicalIF":5.8000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569458/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Stroke Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/23969873241254239","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Too few patients benefit from endovascular therapy (EVT) in large vessel occlusion acute stroke (LVOS), and various acute stroke care paradigms are currently investigated to reduce these inequalities in health access. We aimed to investigate whether newly set-up thrombectomy-capable stroke centers (TSC) offered a safe, effective and cost-effective procedure.

Patients and methods: This French retrospective study compared the outcomes of LVOS patients with an indication for EVT and treated at the Perpignan hospital before on-site thrombectomy was available (Primary stroke center), and after formation of local radiology team for neurointervention (TSC). Primary endpoints were 3-months functional outcomes, assessed by the modified Rankin scale. Various safety endpoints for ischemic and hemorragic procedural complications were assessed. We conducted a medico-economic analysis to estimate the cost-benefit of becoming a TSC for the hospital.

Results: The differences between 422 patients in the PSC and 266 in the TSC were adjusted by the means of weighted logistic regression. Patients treated in the TSC had higher odds of excellent functional outcome (aOR 1.77 [1.16-2.72], p = 0.008), with no significant differences in the rates of procedural complications. The TSC setting shortened onset-to-reperfusion times by 144 min (95% CI [131-155]; p < 0.0001), and was cost-effective after 21 treated LVOS patients. On-site thrombectomy saves 10.825€ per patient for the hospital.

Discussion: Our results demonstrate that the TSC setting improves functional outcomes and reduces intra-hospital costs in LVOS patients. TSCs could play a major public health role in acute stroke care and access to EVT.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
成为具备血栓切除能力的中风中心:医院层面的临床和医疗经济效益。
导言:在大血管闭塞性急性卒中(LVOS)中,从血管内治疗(EVT)中获益的患者太少,目前正在研究各种急性卒中治疗模式,以减少医疗服务中的不平等。我们的目的是调查新成立的具有血栓切除能力的中风中心(TSC)是否能提供安全、有效和经济的治疗方法:这项法国回顾性研究比较了在佩皮尼昂医院接受现场血栓切除术之前(初级卒中中心)和当地神经介入放射学团队成立之后(TSC)治疗的有 EVT 适应症的 LVOS 患者的疗效。主要终点是3个月的功能结果,采用改良Rankin量表进行评估。我们还评估了缺血性和血栓性手术并发症的各种安全性终点。我们还进行了医疗经济分析,以估算医院成为 TSC 的成本效益:通过加权逻辑回归调整了422名PSC患者和266名TSC患者之间的差异。在TSC接受治疗的患者获得极佳功能预后的几率更高(aOR 1.77 [1.16-2.72],p = 0.008),手术并发症发生率无显著差异。TSC 设置将起始到再灌注时间缩短了 144 分钟(95% CI [131-155];P 讨论):我们的研究结果表明,TSC 可改善 LVOS 患者的功能预后并降低院内费用。TSC 可在急性卒中救治和 EVT 治疗中发挥重要的公共卫生作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.50
自引率
6.60%
发文量
102
期刊介绍: Launched in 2016 the European Stroke Journal (ESJ) is the official journal of the European Stroke Organisation (ESO), a professional non-profit organization with over 1,400 individual members, and affiliations to numerous related national and international societies. ESJ covers clinical stroke research from all fields, including clinical trials, epidemiology, primary and secondary prevention, diagnosis, acute and post-acute management, guidelines, translation of experimental findings into clinical practice, rehabilitation, organisation of stroke care, and societal impact. It is open to authors from all relevant medical and health professions. Article types include review articles, original research, protocols, guidelines, editorials and letters to the Editor. Through ESJ, authors and researchers have gained a new platform for the rapid and professional publication of peer reviewed scientific material of the highest standards; publication in ESJ is highly competitive. The journal and its editorial team has developed excellent cooperation with sister organisations such as the World Stroke Organisation and the International Journal of Stroke, and the American Heart Organization/American Stroke Association and the journal Stroke. ESJ is fully peer-reviewed and is a member of the Committee on Publication Ethics (COPE). Issues are published 4 times a year (March, June, September and December) and articles are published OnlineFirst prior to issue publication.
期刊最新文献
Etiologic subtypes of first and recurrent ischemic stroke in young patients using A-S-C-O and TOAST classification criteria: A retrospective follow-up study. Quality of early stroke care and long-term mortality in patients with acute stroke: A nationwide follow-up study. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies. Epidemiology of transient ischemic attack in the Normandy Stroke population-based study. EnDovascular therapy plus best medical treatment (BMT) versus BMT alone for medIum distal veSsel occlusion sTroke (DISTAL): An international, multicentre, randomized-controlled, two-arm, assessor-blinded trial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1